Mangoceuticals Inc. (NASDAQ: MGRX) announced on April 25, 2025, its strategic entry into the oral pouch delivery market through the acquisition of all intellectual property, product formulations, know-how, distribution, and supplier relationships from Smokeless Technology Corp. This Canadian-based company specializes in stimulant and functional pouches.
The acquisition positions Mangoceuticals to capitalize on the rapidly expanding oral pouch market, which the company believes is one of the fastest-growing sectors in consumer wellness. The U.S. nicotine pouch market alone reached $3.13 billion in 2024, with the global oral pouch market projected to exceed $37.34 billion by 2032.
As part of this strategic expansion, Mangoceuticals appointed Tim Corkum, a veteran from Philip Morris International and former President of JUUL Labs Canada, to lead its new Pouch Division. Mr. Corkum's extensive experience in consumer packaged goods and smoke-free initiatives is expected to drive the development and commercialization of new branded non-pharmaceutical and nutraceutical products, as well as integrate stimulant formulations with pharmaceutical ingredients.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.